Skip to main content
Top
Published in: Modern Rheumatology 6/2010

01-12-2010 | Original Article

Evaluation of quality of life in relation to anxiety and depression in primary Sjögren’s syndrome

Authors: Vedat Inal, Gul Kitapcioglu, Gonca Karabulut, Gökhan Keser, Yasemin Kabasakal

Published in: Modern Rheumatology | Issue 6/2010

Login to get access

Abstract

The aim of this study was to evaluate health-related quality of life (HR-QOL) in patients with primary Sjögren’s syndrome (pSS) using both Short-Form 36 (SF-36) and World Health Organization Quality of Life Assessment–BREF (WHOQOL-BREF) questionnaires and to determine the effects of anxiety and depression on HR-QOL using the Hospital Anxiety–Depression Scale (HADS). In this cross-sectional study, 107 female patients with pSS (mean age 54.10 ± 10.2 years), fulfilling US–European Consensus Criteria and 109 female controls (mean age 53.4 ± 10.9 years) were included. Student’s t test, Mann–Whitney U test, and analysis of variance (ANOVA) were used for statistical analysis. P values >0.05 were accepted as significant. All domains of the SF-36, with the exception of “Vitality”, and all domains of the WHOQOL-BREF with the exception of “Environment”, were significantly lower in pSS patients compared with healthy controls. In pSS patients having anxiety according to HADS, the scores of all domains of WHOQOL-BREF were significantly lower, and in patients having depression according to HADS, three of four domains of WHOQOL-BREF were significantly lower compared with the rest of the group. However, the scores of two domains of the SF-36, namely “Role-Physical” and “Role-Emotional” domains, were significantly higher in pSS patients having depression according to HADS. We confirmed the presence of impaired HR-QOL in pSS. Whereas the presence of anxiety and/or depression generally showed a negative affect on HR-QOL, interestingly, depression seemed to improve the scores of “Role-Physical” and “Role-Emotional” domains of the SF-36. This surprising finding might be related to adaptation to changing health. Social support based upon cultural traditions might also have contributed.
Literature
1.
go back to reference Tzioufas AG, Mitsias ID, Mouthsopoulos HM. Sjögren’s syndrome. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology, vol. II. 4th ed. Mosby: Elsevier; 2008. p. 1341–52. Tzioufas AG, Mitsias ID, Mouthsopoulos HM. Sjögren’s syndrome. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology, vol. II. 4th ed. Mosby: Elsevier; 2008. p. 1341–52.
3.
go back to reference Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM. Sjogren’s syndrome: why autoimmune epithelitis? Oral Dis. 2006;12:523–32.PubMedCrossRef Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM. Sjogren’s syndrome: why autoimmune epithelitis? Oral Dis. 2006;12:523–32.PubMedCrossRef
4.
go back to reference Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Durusoy R, Mete N, et al. The prevalence of Sjögren’s syndrome in adult women. Scand J Rheumatol. 2006;35:379–83.PubMedCrossRef Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Durusoy R, Mete N, et al. The prevalence of Sjögren’s syndrome in adult women. Scand J Rheumatol. 2006;35:379–83.PubMedCrossRef
5.
go back to reference Thomas E, Hay EM, Hajeer A, Silman J. Sjögren’s syndrome: a community-based study of prevalence and impact. Br J Rheumatol. 1998;37:1069–76.PubMedCrossRef Thomas E, Hay EM, Hajeer A, Silman J. Sjögren’s syndrome: a community-based study of prevalence and impact. Br J Rheumatol. 1998;37:1069–76.PubMedCrossRef
6.
go back to reference Boonen A, Rasker JJ, Stucki G. The international classification for functioning, disability and health. A challenge and a need for rheumatology. Clin Rheumatol. 2007;26:1803–8.PubMedCrossRef Boonen A, Rasker JJ, Stucki G. The international classification for functioning, disability and health. A challenge and a need for rheumatology. Clin Rheumatol. 2007;26:1803–8.PubMedCrossRef
7.
go back to reference Szabo S. The World Health Organisation Quality of life (WHOQOL) assesment instrument. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd edn. Philadelphia: Lipincot-Raven; 1996. p. 355–62. Szabo S. The World Health Organisation Quality of life (WHOQOL) assesment instrument. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd edn. Philadelphia: Lipincot-Raven; 1996. p. 355–62.
8.
go back to reference Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. J Am Med Assoc. 1989;262:907–13.CrossRef Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. J Am Med Assoc. 1989;262:907–13.CrossRef
9.
go back to reference Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology (Oxford). 2009;48(9):1077–82.CrossRef Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology (Oxford). 2009;48(9):1077–82.CrossRef
10.
go back to reference Bjerrum K, Prause JU. Primary Sjogren’s syndrome: a subjective description of the disease. Clin Exp Rheumatol. 1990;8:283–8.PubMed Bjerrum K, Prause JU. Primary Sjogren’s syndrome: a subjective description of the disease. Clin Exp Rheumatol. 1990;8:283–8.PubMed
11.
go back to reference The WHOQOL Group. Development of the WHOQOL: rationale and current status. Int J Ment Health. 1994;23(3):24–56. The WHOQOL Group. Development of the WHOQOL: rationale and current status. Int J Ment Health. 1994;23(3):24–56.
12.
go back to reference The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551–8.CrossRef The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551–8.CrossRef
13.
go back to reference Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef
14.
go back to reference Bjelland I, Dahl AA, Haung TT, Neckelman D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.PubMedCrossRef Bjelland I, Dahl AA, Haung TT, Neckelman D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.PubMedCrossRef
15.
go back to reference Fidaner H, Elbi H, Fidaner C, Eser SY, Eser E, Goker E. Measuring quality of life WHOQOL-100 and WHOQOL-bref. J Psychiatr Psychol Psychopharmacol. 1999;7:23–41. Fidaner H, Elbi H, Fidaner C, Eser SY, Eser E, Goker E. Measuring quality of life WHOQOL-100 and WHOQOL-bref. J Psychiatr Psychol Psychopharmacol. 1999;7:23–41.
16.
go back to reference Koçyigit H, Aydemir O, Fisek G, Olmez N, Memis A. Turkish validity and reliability of short-form 36. Drug Treat. 1999;12:102–6. Koçyigit H, Aydemir O, Fisek G, Olmez N, Memis A. Turkish validity and reliability of short-form 36. Drug Treat. 1999;12:102–6.
17.
go back to reference Dündar P, Fidaner C, Fidaner H, Oral A, Eser S, Atman UC, et al. Comparing the Turkish versions of WHOQOL-BREF and SF-36. Convergent validity of WHOQOL-BREF and SF-36. Hippokratia. 2002;6(Suppl 1):37–43. Dündar P, Fidaner C, Fidaner H, Oral A, Eser S, Atman UC, et al. Comparing the Turkish versions of WHOQOL-BREF and SF-36. Convergent validity of WHOQOL-BREF and SF-36. Hippokratia. 2002;6(Suppl 1):37–43.
18.
go back to reference Aydemir Ö, Güvenir T, Küey L, Kültür S. Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun geçerlilik ve güvenilirliği. Türk Psikiyatri Derg. 1997;8:187–280. Aydemir Ö, Güvenir T, Küey L, Kültür S. Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun geçerlilik ve güvenilirliği. Türk Psikiyatri Derg. 1997;8:187–280.
19.
go back to reference Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjogren’s syndrome using a new questionnaire tool. Rheumatology. 2004;43:758–64.PubMedCrossRef Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjogren’s syndrome using a new questionnaire tool. Rheumatology. 2004;43:758–64.PubMedCrossRef
20.
go back to reference McMillan AS, Leung KC, Leung WK, Wong MC, Lau CS, Mok TM. Impact of Sjögren’s syndrome on oral health-related quality of life in southern Chinese. J Oral Rehabil. 2004;31(7):653–9.PubMedCrossRef McMillan AS, Leung KC, Leung WK, Wong MC, Lau CS, Mok TM. Impact of Sjögren’s syndrome on oral health-related quality of life in southern Chinese. J Oral Rehabil. 2004;31(7):653–9.PubMedCrossRef
21.
go back to reference Rostron J, Rogers S, Longman L, Kaney S, Field EA. Health-related quality of life in patients with primary Sjögren’s syndrome and xerostomia: a comparative study. Gerodontology. 2002;19(1):53–9.PubMedCrossRef Rostron J, Rogers S, Longman L, Kaney S, Field EA. Health-related quality of life in patients with primary Sjögren’s syndrome and xerostomia: a comparative study. Gerodontology. 2002;19(1):53–9.PubMedCrossRef
22.
go back to reference Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, et al. Primary Sjögren’s syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;27(7):46.CrossRef Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, et al. Primary Sjögren’s syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;27(7):46.CrossRef
23.
go back to reference Baturone R, Soto M, Marquez M, Macias I, Montes de Oca M, Medina F, et al. Health-related quality of life in patients with primary Sjogren’s syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol. 2009;2:1–4. Baturone R, Soto M, Marquez M, Macias I, Montes de Oca M, Medina F, et al. Health-related quality of life in patients with primary Sjogren’s syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol. 2009;2:1–4.
24.
go back to reference Belenguer R, Ramos-Casals M, Brito-Zerón P, del Pino J, Sentís J, Aguiló S, et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2005;23(3):351–6.PubMed Belenguer R, Ramos-Casals M, Brito-Zerón P, del Pino J, Sentís J, Aguiló S, et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2005;23(3):351–6.PubMed
25.
go back to reference Strömbeck B, Ekdahl C, Manthorpe R, Wikström I, Jacobsson L. Health-related quality of life in primary Sjögren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol. 2000;29(1):20–8.PubMedCrossRef Strömbeck B, Ekdahl C, Manthorpe R, Wikström I, Jacobsson L. Health-related quality of life in primary Sjögren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol. 2000;29(1):20–8.PubMedCrossRef
26.
go back to reference Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection. J Am Dent Assoc. 2008;139(3):291–9.PubMed Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection. J Am Dent Assoc. 2008;139(3):291–9.PubMed
27.
go back to reference Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjogren’s syndrome (SS), and primary SS. J Rheumatol. 1998;25:63–8.PubMed Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjogren’s syndrome (SS), and primary SS. J Rheumatol. 1998;25:63–8.PubMed
28.
go back to reference Tensing EK, Solovieva SA, Tervahartiala T, Nordström DC, Laine M, Niissalo S, et al. Fatigue and health profile in sicca syndrome of Sjogren’s and non-Sjogren’s syndrome origin. Clin Exp Rheumatol. 2001;19:313–6.PubMed Tensing EK, Solovieva SA, Tervahartiala T, Nordström DC, Laine M, Niissalo S, et al. Fatigue and health profile in sicca syndrome of Sjogren’s and non-Sjogren’s syndrome origin. Clin Exp Rheumatol. 2001;19:313–6.PubMed
29.
go back to reference Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caumont C, et al. Quality of life and psychological status in patients with primary Sjögren’s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum (Arthritis Care Res). 2006;55:451–7.CrossRef Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caumont C, et al. Quality of life and psychological status in patients with primary Sjögren’s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum (Arthritis Care Res). 2006;55:451–7.CrossRef
30.
go back to reference Stevenson HA, Jones ME, Rostron JL, Longman LP, Field EA. UK patients with primary Sjögren’s syndrome are at increased risk from clinical depression. Gerodontology. 2004;21:141–5.PubMedCrossRef Stevenson HA, Jones ME, Rostron JL, Longman LP, Field EA. UK patients with primary Sjögren’s syndrome are at increased risk from clinical depression. Gerodontology. 2004;21:141–5.PubMedCrossRef
31.
go back to reference Valtýsdóttir ST, Gudbjörnsson B, Hällgren R, Hetta J. Psychological well-being in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2000;18(5):597–600.PubMed Valtýsdóttir ST, Gudbjörnsson B, Hällgren R, Hetta J. Psychological well-being in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2000;18(5):597–600.PubMed
32.
go back to reference Valtýsdóttir ST, Gudbjörnsson B, Lindqvist U, Hällgren R, Hetta J. Anxiety and depression in patients with primary Sjögren’s syndrome. J Rheumatol. 2000;27(1):165–9.PubMed Valtýsdóttir ST, Gudbjörnsson B, Lindqvist U, Hällgren R, Hetta J. Anxiety and depression in patients with primary Sjögren’s syndrome. J Rheumatol. 2000;27(1):165–9.PubMed
33.
go back to reference Kuyken W, Orley J, Hudelson P, Sartorius N. Quality of life assessment across cultures. Int J Ment Health. 1994;23:5–27. Kuyken W, Orley J, Hudelson P, Sartorius N. Quality of life assessment across cultures. Int J Ment Health. 1994;23:5–27.
34.
go back to reference Huang PC, Fang CT, Chang YY, Chen MY, Wang JD. Comparison of WHOQOL-BREF and SF-36 in patients with HIV infection. Qual Life Res. 2005;14:141–50.CrossRef Huang PC, Fang CT, Chang YY, Chen MY, Wang JD. Comparison of WHOQOL-BREF and SF-36 in patients with HIV infection. Qual Life Res. 2005;14:141–50.CrossRef
35.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on Classification Criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.PubMedCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. European Study Group on Classification Criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.PubMedCrossRef
36.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardieri C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:160–72.PubMedCrossRef Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardieri C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:160–72.PubMedCrossRef
37.
go back to reference Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81:270–80.CrossRef Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81:270–80.CrossRef
38.
go back to reference Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res. 2003;12:599–607.PubMedCrossRef Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res. 2003;12:599–607.PubMedCrossRef
39.
go back to reference Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62(1):115–26.PubMedCrossRef Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62(1):115–26.PubMedCrossRef
Metadata
Title
Evaluation of quality of life in relation to anxiety and depression in primary Sjögren’s syndrome
Authors
Vedat Inal
Gul Kitapcioglu
Gonca Karabulut
Gökhan Keser
Yasemin Kabasakal
Publication date
01-12-2010
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 6/2010
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-010-0329-z

Other articles of this Issue 6/2010

Modern Rheumatology 6/2010 Go to the issue